Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:20 PM
Ignite Modification Date:
2026-03-26 @ 3:20 PM
NCT ID:
NCT07322120
Eligibility Criteria:
Inclusion Criteria:
1. People between the ages of 19 and 65
2. People with a body mass index (BMI) ≤ 25
3. Diagnosis of polycystic ovary syndrome by a specialist based on the Rotterdam criteria
Exclusion Criteria:
1. Failure of the participant to cooperate during the study
2. Use of drug therapy that affects carbohydrate or fat metabolism (including oral contraceptives, insulin sensitizers, antiepileptic drugs, antipsychotics, statins, and fish oil) within the past 6 months.
3. Planning for pregnancy, pregnant, or breastfeeding
4. In the perimenopausal stage
5. Low blood pressure
6. Presence of other diseases (such as congenital adrenal hyperplasia, Cushing's syndrome, androgen-secreting tumors, hyperprolactinemia, diabetes, thyroid disease, severe cardiovascular, gastrointestinal, renal, and hepatic diseases)
7. Performing high-intensity exercise
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
19 Years
Maximum Age:
65 Years
Study:
NCT07322120
Study Brief:
Protocol Section:
NCT07322120